The global urology supplements market size is expected to reach USD 4.16 billion by 2032, according to a new study by Polaris Market Research. The report “Urology Supplements Market Share, Size, Trends, Industry Analysis Report, By Type (Multi-ingredient, Single-ingredient); By Application; By Formulation; By Distribution Channel; By Region; Segment Forecast, 2023 - 2032” gives a detailed insight into current market dynamics and provides analysis on future market growth.
The increasing focus on developing prominent health supplements for the treatment of urology-based health problems is positively driving the global market. The presence of established healthcare regulators is enhancing consumer safety. For instance, in November 2023, after successful clinical trials, the United Nations Food and Drug Administration announced the approval of Enzalutamide for the treatment of prostate cancer in a Nonmetastatic Hormone-Sensitive setting.
As per the statistics published by the Centers for Disease Control and Prevention (CDC), nearly 37 Mn individuals in the U.S. were living with chronic kidney disease (CKD), while 726,000 have end-stage CKD. Moreover, in June 2023, Somatus & Kidney Care Center extended their partnership to promote accessibility to customized resources & support for
Global urology supplements are witnessing increased demand, with charging individuals' eating patterns driven by the availability of several ultra-processed and convenience foods. According to the 2023 study published in Nature Review Urology magazine, obesity can lead to mortality and aggressive and high-grade prostate cancer among individuals. The limited time for preparing meals at home and the lack of regular exercise due to the hectic work schedules among the households are major factors causing obesity, thereby causing prostate cancer and other kidney-related health issues among people.
The rising number of prostate cancer cases in developed countries is becoming a huge difficulty for the government, primarily in the United States and the U.K. According to Cancer Research U.K., the penetration rate of prostate cancer is expected to grow by 15% from 2023-2025 and 2038-2040.
Do you have any questions? Would you like to request a sample or make an inquiry before purchasing this report? Simply click the link below:https://www.polarismarketresearch.com/industry-analysis/urology-supplements-market/request-for-sample
People are showing interest in preventive care in the marketplace with a view to safeguarding themselves from deadly diseases. This is forcing pharmaceutical companies to formulate preventive care medications. For instance, in January 2024, Theralogix unveiled its new supplement, Mannose One, to prevent the incidence of urinary tract infections by removing the attachment of bacteria to the bladder lining.
Urology Supplements Market Report Highlights
Polaris Market Research has segmented the urology supplements market report based on type, application, formulation, distribution channel, and region:
Urology Supplements, Type Outlook (Revenue - USD Billion, 2019 - 2032)
Urology Supplements, Application Outlook (Revenue - USD Billion, 2019 - 2032)
Urology Supplements, Formulation Outlook (Revenue - USD Billion, 2019 - 2032)
Urology Supplements, Distribution Channel Outlook (Revenue - USD Billion, 2019 -
Urology Supplements, Regional Outlook (Revenue - USD Billion, 2019 - 2032)
Report Attributes |
Details |
Market size value in 2024 |
USD 2.29 billion |
Revenue forecast in 2032 |
USD 4.16 billion |
CAGR |
7.8% from 2024 – 2032 |
Base year |
2023 |
Historical data |
2019 – 2022 |
Forecast period |
2024 – 2032 |
Quantitative units |
Revenue in USD billion and CAGR from 2024 to 2032 |
Segments covered |
|
Regional scope |
|
Competitive Landscape |
|
Report Format |
|
Customization |
Report customization as per your requirements with respect to countries, region and segmentation. |
For Specific Research Requirements |